2024 Q2 Form 10-Q Financial Statement

#000176640024000056 Filed on May 06, 2024

View on sec.gov

Income Statement

Concept 2024 Q2 2024 Q1
Revenue $168.7M $156.9M
YoY Change 27.57% 24.08%
Cost Of Revenue $134.2M $124.4M
YoY Change 26.83% 23.34%
Gross Profit $34.55M $32.50M
YoY Change 30.52% 26.98%
Gross Profit Margin 20.47% 20.71%
Selling, General & Admin $11.88M $11.44M
YoY Change 35.12% -41.75%
% of Gross Profit 34.38% 35.19%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $1.468M $1.331M
YoY Change 21.22% 3.98%
% of Gross Profit 4.25% 4.1%
Operating Expenses $11.88M $11.44M
YoY Change 35.12% -45.32%
Operating Profit $9.562M $8.524M
YoY Change 52.72% 99.16%
Interest Expense -$1.624M $1.792M
YoY Change -211.77% 27.45%
% of Operating Profit -16.98% 21.02%
Other Income/Expense, Net -$2.000K $85.00K
YoY Change -105.71% 183.33%
Pretax Income $7.938M $6.817M
YoY Change 63.91% 134.75%
Income Tax $1.844M $1.759M
% Of Pretax Income 23.23% 25.8%
Net Earnings $5.690M $4.906M
YoY Change 103.43% 165.19%
Net Earnings / Revenue 3.37% 3.13%
Basic Earnings Per Share $0.19 $0.16
Diluted Earnings Per Share $0.18 $0.16
COMMON SHARES
Basic Shares Outstanding 30.05M shares 30.01M shares
Diluted Shares Outstanding 30.78M shares 30.40M shares

Balance Sheet

Concept 2024 Q2 2024 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $3.043M $2.722M
YoY Change 7.22% -7.79%
Cash & Equivalents $3.043M $2.722M
Short-Term Investments
Other Short-Term Assets $14.98M $12.99M
YoY Change 29.72% -1.16%
Inventory
Prepaid Expenses
Receivables $76.09M $71.35M
Other Receivables $0.00 $0.00
Total Short-Term Assets $94.11M $87.06M
YoY Change 31.37% 30.43%
LONG-TERM ASSETS
Property, Plant & Equipment $40.91M $40.59M
YoY Change 50.1% 50.64%
Goodwill $110.5M $107.2M
YoY Change 32.14% 34.87%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $12.07M $9.651M
YoY Change 8.19% -19.74%
Total Long-Term Assets $508.4M $491.2M
YoY Change 14.55% 11.28%
TOTAL ASSETS
Total Short-Term Assets $94.11M $87.06M
Total Long-Term Assets $508.4M $491.2M
Total Assets $602.5M $578.2M
YoY Change 16.89% 13.79%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $15.39M $13.06M
YoY Change 27.87% 7.39%
Accrued Expenses $57.51M $50.68M
YoY Change 22.54% 28.66%
Deferred Revenue $1.706M $1.793M
YoY Change -6.21% 11.44%
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $83.69M $75.24M
YoY Change 22.21% 14.64%
LONG-TERM LIABILITIES
Long-Term Debt $82.17M $83.29M
YoY Change 38.92% 46.07%
Other Long-Term Liabilities $10.66M $9.162M
YoY Change 37.06% 46.83%
Total Long-Term Liabilities $10.66M $9.162M
YoY Change 37.06% 46.83%
TOTAL LIABILITIES
Total Short-Term Liabilities $83.69M $75.24M
Total Long-Term Liabilities $10.66M $9.162M
Total Liabilities $429.5M $414.0M
YoY Change 12.51% 9.26%
SHAREHOLDERS EQUITY
Retained Earnings $45.26M $39.57M
YoY Change 74.54% 71.04%
Common Stock $30.00K $30.00K
YoY Change 3.45% 3.45%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $155.5M $147.2M
YoY Change
Total Liabilities & Shareholders Equity $602.5M $578.2M
YoY Change 16.89% 13.79%

Cashflow Statement

Concept 2024 Q2 2024 Q1
OPERATING ACTIVITIES
Net Income $5.690M $4.906M
YoY Change 103.43% 165.19%
Depreciation, Depletion And Amortization $1.468M $1.331M
YoY Change 21.22% 3.98%
Cash From Operating Activities $10.49M $545.0K
YoY Change 60.49% -93.94%
INVESTING ACTIVITIES
Capital Expenditures $2.618M $3.144M
YoY Change 57.81% 35.87%
Acquisitions
YoY Change
Other Investing Activities -$7.026M -$10.11M
YoY Change -2.97% 84166.67%
Cash From Investing Activities -$9.644M -$23.64M
YoY Change 8.36% 916.17%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -526.0K $19.75M
YoY Change -123.39% -440.76%
NET CHANGE
Cash From Operating Activities 10.49M $545.0K
Cash From Investing Activities -9.644M -$23.64M
Cash From Financing Activities -526.0K $19.75M
Net Change In Cash 321.0K -$3.337M
YoY Change -381.58% -482.25%
FREE CASH FLOW
Cash From Operating Activities $10.49M $545.0K
Capital Expenditures $2.618M $3.144M
Free Cash Flow $7.873M -$2.599M
YoY Change 61.4% -138.9%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2024Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
9162000 usd
CY2023Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
8262000 usd
CY2024Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
578243000 usd
CY2024Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
156915000 usd
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
126464000 usd
CY2024Q1 us-gaap Other Restricted Assets Noncurrent
OtherRestrictedAssetsNoncurrent
9651000 usd
CY2023Q4 us-gaap Other Restricted Assets Noncurrent
OtherRestrictedAssetsNoncurrent
9337000 usd
CY2024Q1 us-gaap Goodwill
Goodwill
107220000 usd
CY2023Q4 us-gaap Goodwill
Goodwill
91014000 usd
CY2024Q1 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
74942000 usd
CY2023Q4 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
67742000 usd
CY2024Q1 us-gaap Assets
Assets
578243000 usd
CY2023Q4 us-gaap Assets
Assets
539691000 usd
CY2024Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
13060000 usd
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
10841000 usd
CY2024Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
25254000 usd
CY2023Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
28256000 usd
CY2024Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
17378000 usd
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
17122000 usd
CY2024Q1 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
19543000 usd
CY2023Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
15330000 usd
CY2024Q1 us-gaap Liabilities Current
LiabilitiesCurrent
75235000 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
71549000 usd
CY2024Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
244180000 usd
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
248596000 usd
CY2024Q1 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
2140000 usd
CY2023Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
1855000 usd
CY2024Q1 us-gaap Long Term Debt
LongTermDebt
83294000 usd
CY2023Q4 us-gaap Long Term Debt
LongTermDebt
63914000 usd
CY2024Q1 us-gaap Liabilities
Liabilities
414011000 usd
CY2023Q4 us-gaap Liabilities
Liabilities
394176000 usd
CY2024Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2024Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2024Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2024Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
30371000 shares
CY2024Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
30036000 shares
CY2024Q1 us-gaap Common Stock Value
CommonStockValue
30000 usd
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
29000 usd
CY2024Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
107644000 usd
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
105712000 usd
CY2024Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
39569000 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
34663000 usd
CY2024Q1 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
3000 shares
CY2023Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
3000 shares
CY2024Q1 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
65000 usd
CY2023Q4 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
65000 usd
CY2024Q1 pntg Net Parent Investment
NetParentInvestment
147178000 usd
CY2023Q4 pntg Net Parent Investment
NetParentInvestment
140339000 usd
CY2024Q1 us-gaap Minority Interest
MinorityInterest
17054000 usd
CY2023Q4 us-gaap Minority Interest
MinorityInterest
5176000 usd
CY2024Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
164232000 usd
CY2023Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
145515000 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
539691000 usd
CY2024Q1 us-gaap Cost Of Goods And Service Excluding Depreciation Depletion And Amortization
CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
125995000 usd
CY2023Q1 us-gaap Cost Of Goods And Service Excluding Depreciation Depletion And Amortization
CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
102602000 usd
CY2024Q1 us-gaap Operating Lease Expense
OperatingLeaseExpense
10384000 usd
CY2023Q1 us-gaap Operating Lease Expense
OperatingLeaseExpense
9597000 usd
CY2024Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
11436000 usd
CY2023Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
8705000 usd
CY2024Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
1331000 usd
CY2023Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
1280000 usd
CY2024Q1 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
755000 usd
CY2023Q1 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
0 usd
CY2024Q1 us-gaap Costs And Expenses
CostsAndExpenses
148391000 usd
CY2023Q1 us-gaap Costs And Expenses
CostsAndExpenses
122184000 usd
CY2024Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
8524000 usd
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
4280000 usd
CY2024Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
85000 usd
CY2023Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
30000 usd
CY2024Q1 us-gaap Interest Expense
InterestExpense
1792000 usd
CY2023Q1 us-gaap Interest Expense
InterestExpense
1406000 usd
CY2024Q1 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-1707000 usd
CY2023Q1 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-1376000 usd
CY2024Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
6817000 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
2904000 usd
CY2024Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1759000 usd
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
907000 usd
CY2024Q1 us-gaap Profit Loss
ProfitLoss
5058000 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
1997000 usd
CY2024Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
152000 usd
CY2023Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
147000 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
4906000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
1850000 usd
CY2024Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.16
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.06
CY2024Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.16
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.06
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
30046000 shares
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
29751000 shares
CY2024Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
30403000 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
30147000 shares
CY2023Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
145515000 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
4906000 usd
CY2024Q1 us-gaap Noncontrolling Interest Increase From Business Combination
NoncontrollingInterestIncreaseFromBusinessCombination
11726000 usd
CY2024Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
152000 usd
CY2024Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1440000 usd
CY2024Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
493000 usd
CY2024Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
164232000 usd
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
125657000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
1850000 usd
CY2023Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
147000 usd
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1367000 usd
CY2023Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
203000 usd
CY2023Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
129224000 usd
CY2024Q1 us-gaap Profit Loss
ProfitLoss
5058000 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
1997000 usd
CY2024Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1331000 usd
CY2023Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1280000 usd
CY2024Q1 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
130000 usd
CY2023Q1 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
130000 usd
CY2024Q1 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
755000 usd
CY2023Q1 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
0 usd
CY2024Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
244000 usd
CY2023Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
151000 usd
CY2024Q1 us-gaap Share Based Compensation
ShareBasedCompensation
1440000 usd
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
1367000 usd
CY2024Q1 us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
285000 usd
CY2023Q1 us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
776000 usd
CY2024Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
10483000 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-3166000 usd
CY2024Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
1298000 usd
CY2023Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-4317000 usd
CY2024Q1 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-13000 usd
CY2023Q1 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-18000 usd
CY2024Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
2414000 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-772000 usd
CY2024Q1 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-3001000 usd
CY2023Q1 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-2788000 usd
CY2024Q1 us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
2922000 usd
CY2023Q1 us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
-1077000 usd
CY2024Q1 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
536000 usd
CY2023Q1 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
0 usd
CY2024Q1 us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
1735000 usd
CY2023Q1 us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
467000 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
545000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
8996000 usd
CY2024Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
3144000 usd
CY2023Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2314000 usd
CY2024Q1 us-gaap Payments To Acquire Businesses Gross
PaymentsToAcquireBusinessesGross
11680000 usd
CY2023Q1 us-gaap Payments To Acquire Businesses Gross
PaymentsToAcquireBusinessesGross
0 usd
CY2024Q1 pntg Paymentsfor Asset Acquisitions
PaymentsforAssetAcquisitions
10380000 usd
CY2023Q1 pntg Paymentsfor Asset Acquisitions
PaymentsforAssetAcquisitions
210000 usd
CY2024Q1 pntg Payments For Deposits On Acquisition
PaymentsForDepositsOnAcquisition
-248000 usd
CY2023Q1 pntg Payments For Deposits On Acquisition
PaymentsForDepositsOnAcquisition
0 usd
CY2024Q1 pntg Payments For Proceeds From Property Reserve Requirements
PaymentsForProceedsFromPropertyReserveRequirements
-1320000 usd
CY2023Q1 pntg Payments For Proceeds From Property Reserve Requirements
PaymentsForProceedsFromPropertyReserveRequirements
-198000 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-23636000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-2326000 usd
CY2024Q1 us-gaap Proceeds From Long Term Lines Of Credit
ProceedsFromLongTermLinesOfCredit
69000000 usd
CY2023Q1 us-gaap Proceeds From Long Term Lines Of Credit
ProceedsFromLongTermLinesOfCredit
40500000 usd
CY2024Q1 us-gaap Repayments Of Long Term Lines Of Credit
RepaymentsOfLongTermLinesOfCredit
49750000 usd
CY2023Q1 us-gaap Repayments Of Long Term Lines Of Credit
RepaymentsOfLongTermLinesOfCredit
46500000 usd
CY2024Q1 pntg Finance Lease Obligations Financing Activities
FinanceLeaseObligationsFinancingActivities
11000 usd
CY2023Q1 pntg Finance Lease Obligations Financing Activities
FinanceLeaseObligationsFinancingActivities
0 usd
CY2024Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
493000 usd
CY2023Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
203000 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
19754000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-5797000 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-3337000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
873000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
6059000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2079000 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2722000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2952000 usd
CY2024Q1 us-gaap Interest Paid Net
InterestPaidNet
1711000 usd
CY2023Q1 us-gaap Interest Paid Net
InterestPaidNet
1536000 usd
CY2024Q1 us-gaap Proceeds From Income Tax Refunds
ProceedsFromIncomeTaxRefunds
41000 usd
CY2023Q1 us-gaap Proceeds From Income Tax Refunds
ProceedsFromIncomeTaxRefunds
30000 usd
CY2024Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
9471000 usd
CY2023Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
8927000 usd
CY2024Q1 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
755000 usd
CY2023Q1 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
7489000 usd
CY2024Q1 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
125000 usd
CY2023Q1 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
566000 usd
CY2024Q1 us-gaap Nature Of Operations
NatureOfOperations
DESCRIPTION OF BUSINESS<div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Pennant Group, Inc. (herein referred to as “Pennant,” the “Company,” “it,” or “its”), is a holding company with no direct operating assets, employees or revenue. The Company, through its independent operating subsidiaries, provides healthcare services across the post-acute care continuum. As of March 31, 2024, the Company’s subsidiaries operated 112 home health, hospice and home care agencies and 53 senior living communities located in Arizona, California, Colorado, Idaho, Montana, Nevada, Oklahoma, Oregon, Texas, Utah, Washington, Wisconsin and Wyoming. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain of the Company’s subsidiaries, collectively referred to as the Service Center, provide accounting, payroll, human resources, information technology, legal, risk management, and other services to the operations through contractual relationships. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each of the Company’s affiliated operations are operated by separate, independent subsidiaries that have their own management, employees and assets. References herein to the consolidated “Company” and “its” assets and activities are not meant to imply, nor should they be construed as meaning, that Pennant has direct operating assets, employees or revenue, or that any of the subsidiaries are operated by Pennant.</span></div>
CY2024Q1 pntg Deferred State Relief Funds Current
DeferredStateReliefFundsCurrent
383000 usd
CY2023Q4 pntg Deferred State Relief Funds Current
DeferredStateReliefFundsCurrent
780000 usd
CY2024Q1 pntg State Relief Funds Reduction
StateReliefFundsReduction
453000 usd
CY2023Q1 pntg State Relief Funds Reduction
StateReliefFundsReduction
685000 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
4906000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
1850000 usd
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
30046000 shares
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
29751000 shares
CY2024Q1 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
357000 shares
CY2023Q1 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
396000 shares
CY2024Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
30403000 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
30147000 shares
CY2024Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.16
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.06
CY2024Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.16
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.06
CY2024Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
2043000 shares
CY2023Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
2002000 shares
CY2024Q1 us-gaap Revenue Performance Obligation Description Of Payment Terms
RevenuePerformanceObligationDescriptionOfPaymentTerms
Residency agreements are generally for a term of 30 days, with resident fees billed monthly in advance. For residents under reimbursement arrangements with Medicaid, revenue is recorded based on contractually agreed-upon amounts or rates on a per resident, daily basis or as services are rendered.
CY2024Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
156915000 usd
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
126464000 usd
CY2024Q1 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
71551000 usd
CY2023Q4 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
61375000 usd
CY2024Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
197000 usd
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
259000 usd
CY2024Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
71354000 usd
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
61116000 usd
CY2024Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
156915000 usd
CY2024Q1 pntg Income Loss From Continuing Operations Before Interest Taxes Depreciation And Amortization Rent Costs Acquisition Costs And Stock Based Compensation
IncomeLossFromContinuingOperationsBeforeInterestTaxesDepreciationAndAmortizationRentCostsAcquisitionCostsAndStockBasedCompensation
21400000 usd
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
126464000 usd
CY2023Q1 pntg Income Loss From Continuing Operations Before Interest Taxes Depreciation And Amortization Rent Costs Acquisition Costs And Stock Based Compensation
IncomeLossFromContinuingOperationsBeforeInterestTaxesDepreciationAndAmortizationRentCostsAcquisitionCostsAndStockBasedCompensation
17139000 usd
CY2024Q1 pntg Income Loss From Continuing Operations Before Interest Taxes Depreciation And Amortization Rent Costs Acquisition Costs And Stock Based Compensation
IncomeLossFromContinuingOperationsBeforeInterestTaxesDepreciationAndAmortizationRentCostsAcquisitionCostsAndStockBasedCompensation
21400000 usd
CY2023Q1 pntg Income Loss From Continuing Operations Before Interest Taxes Depreciation And Amortization Rent Costs Acquisition Costs And Stock Based Compensation
IncomeLossFromContinuingOperationsBeforeInterestTaxesDepreciationAndAmortizationRentCostsAcquisitionCostsAndStockBasedCompensation
17139000 usd
CY2024Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
1331000 usd
CY2023Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
1280000 usd
CY2024Q1 us-gaap Operating Lease Expense
OperatingLeaseExpense
10384000 usd
CY2023Q1 us-gaap Operating Lease Expense
OperatingLeaseExpense
9597000 usd
CY2024Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
85000 usd
CY2023Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
30000 usd
CY2024Q1 pntg Start Up Activities Costs
StartUpActivitiesCosts
-82000 usd
CY2023Q1 pntg Start Up Activities Costs
StartUpActivitiesCosts
203000 usd
CY2024Q1 pntg Share Based Compensation Expense And Related Taxes
ShareBasedCompensationExpenseAndRelatedTaxes
1526000 usd
CY2023Q1 pntg Share Based Compensation Expense And Related Taxes
ShareBasedCompensationExpenseAndRelatedTaxes
1419000 usd
CY2024Q1 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
137000 usd
CY2023Q1 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
32000 usd
CY2024Q1 pntg Costs Associated With Transitioning Operations
CostsAssociatedWithTransitioningOperations
-628000 usd
CY2023Q1 pntg Costs Associated With Transitioning Operations
CostsAssociatedWithTransitioningOperations
47000 usd
CY2024Q1 pntg Unusual Non Recurring Or Redundant Charges
UnusualNonRecurringOrRedundantCharges
275000 usd
CY2023Q1 pntg Unusual Non Recurring Or Redundant Charges
UnusualNonRecurringOrRedundantCharges
398000 usd
CY2024Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
152000 usd
CY2023Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
147000 usd
CY2024Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
8524000 usd
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
4280000 usd
CY2024Q1 us-gaap Payments To Acquire Interest In Joint Venture
PaymentsToAcquireInterestInJointVenture
11680000 usd
CY2023Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
53675000 usd
CY2024Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
26381000 usd
CY2023Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
25077000 usd
CY2024Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
66973000 usd
CY2024Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
40592000 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
28598000 usd
CY2024Q1 us-gaap Depreciation
Depreciation
1331000 usd
CY2023Q1 us-gaap Depreciation
Depreciation
1275000 usd
CY2023Q4 us-gaap Goodwill
Goodwill
91014000 usd
CY2024Q1 us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
16206000 usd
CY2024Q1 us-gaap Goodwill
Goodwill
107220000 usd
CY2024Q1 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
74942000 usd
CY2023Q4 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
67742000 usd
CY2024Q1 us-gaap Goodwill And Intangible Asset Impairment
GoodwillAndIntangibleAssetImpairment
0 usd
CY2023Q1 us-gaap Goodwill And Intangible Asset Impairment
GoodwillAndIntangibleAssetImpairment
0 usd
CY2024Q1 us-gaap Customer Refund Liability Current
CustomerRefundLiabilityCurrent
1835000 usd
CY2023Q4 us-gaap Customer Refund Liability Current
CustomerRefundLiabilityCurrent
1566000 usd
CY2024Q1 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
1793000 usd
CY2023Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
1658000 usd
CY2024Q1 us-gaap Deposit Liability Current
DepositLiabilityCurrent
2154000 usd
CY2023Q4 us-gaap Deposit Liability Current
DepositLiabilityCurrent
2367000 usd
CY2024Q1 us-gaap Accrual For Taxes Other Than Income Taxes Current
AccrualForTaxesOtherThanIncomeTaxesCurrent
1157000 usd
CY2023Q4 us-gaap Accrual For Taxes Other Than Income Taxes Current
AccrualForTaxesOtherThanIncomeTaxesCurrent
1255000 usd
CY2024Q1 pntg Deferred State Relief Funds Current
DeferredStateReliefFundsCurrent
383000 usd
CY2023Q4 pntg Deferred State Relief Funds Current
DeferredStateReliefFundsCurrent
780000 usd
CY2024Q1 us-gaap Self Insurance Reserve Current
SelfInsuranceReserveCurrent
6504000 usd
CY2023Q4 us-gaap Self Insurance Reserve Current
SelfInsuranceReserveCurrent
4392000 usd
CY2024Q1 us-gaap Other Sundry Liabilities Current
OtherSundryLiabilitiesCurrent
5717000 usd
CY2023Q4 us-gaap Other Sundry Liabilities Current
OtherSundryLiabilitiesCurrent
3312000 usd
CY2024Q1 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
19543000 usd
CY2023Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
15330000 usd
CY2024Q1 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
956000 usd
CY2023Q4 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
1086000 usd
CY2024Q1 us-gaap Long Term Debt
LongTermDebt
83294000 usd
CY2023Q4 us-gaap Long Term Debt
LongTermDebt
63914000 usd
CY2024Q1 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
130000 usd
CY2023Q1 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
130000 usd
CY2024Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1440000 usd
CY2023Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1367000 usd
CY2024Q1 us-gaap Variable Lease Cost
VariableLeaseCost
2030000 usd
CY2023Q1 us-gaap Variable Lease Cost
VariableLeaseCost
1730000 usd
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
28189000 usd
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
36403000 usd
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
34894000 usd
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
33963000 usd
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
33227000 usd
CY2024Q1 pntg Lessee Operating Lease Liability To Be Paid After Year Four
LesseeOperatingLeaseLiabilityToBePaidAfterYearFour
249086000 usd
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
415762000 usd
CY2024Q1 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
154204000 usd
CY2024Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
261558000 usd
CY2024Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
17378000 usd
CY2024Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
244180000 usd
CY2024Q1 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P12Y3M18D
CY2024Q1 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.081
CY2024Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1759000 usd
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
907000 usd
CY2024Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.258
CY2023Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.312
CY2024Q1 us-gaap Defined Contribution Plan Maximum Annual Contributions Per Employee Percent
DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent
0.90
CY2024Q1 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
291000 usd
CY2023Q1 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
213000 usd
CY2024Q1 pntg Deferred Compensation Arrangement With Individual Maximum Deferral Percentage Of Compensation
DeferredCompensationArrangementWithIndividualMaximumDeferralPercentageOfCompensation
0.80
CY2024Q1 pntg Deferred Compensation Arrangement With Individual Minimum Payment Deferral Period
DeferredCompensationArrangementWithIndividualMinimumPaymentDeferralPeriod
P1Y
CY2024Q1 pntg Deferred Compensation Arrangement With Individual Number Of Annual Installments
DeferredCompensationArrangementWithIndividualNumberOfAnnualInstallments
10 installment
CY2024Q1 us-gaap Deferred Compensation Arrangement With Individual Recorded Liability
DeferredCompensationArrangementWithIndividualRecordedLiability
1965000 usd
CY2023Q1 us-gaap Deferred Compensation Arrangement With Individual Recorded Liability
DeferredCompensationArrangementWithIndividualRecordedLiability
855000 usd
CY2024Q1 us-gaap Cash Surrender Value Of Life Insurance
CashSurrenderValueOfLifeInsurance
1997000 usd
CY2023Q1 us-gaap Cash Surrender Value Of Life Insurance
CashSurrenderValueOfLifeInsurance
852000 usd
CY2024Q1 pntg Number Of Operating Subsidiaries With Reviews Scheduled
NumberOfOperatingSubsidiariesWithReviewsScheduled
10 review
CY2024Q1 pntg Uniform Program Integrity Contractor Suspended Payments
UniformProgramIntegrityContractorSuspendedPayments
5105000 usd
CY2024Q1 pntg Uniform Program Integrity Contractor Sampled And Extrapolated Overpayments
UniformProgramIntegrityContractorSampledAndExtrapolatedOverpayments
1774000 usd
CY2022Q2 pntg Uniform Program Integrity Contractor Number Of Patient Records Under Review
UniformProgramIntegrityContractorNumberOfPatientRecordsUnderReview
107 agency
CY2022Q2 pntg Uniform Program Integrity Contractor Period Of Review
UniformProgramIntegrityContractorPeriodOfReview
P10M
CY2024Q1 pntg Uniform Program Integrity Contractor Suspended Payments
UniformProgramIntegrityContractorSuspendedPayments
5105000 usd
CY2024Q1 pntg Uniform Program Integrity Contractor Previously Withheld Amounts
UniformProgramIntegrityContractorPreviouslyWithheldAmounts
3363000 usd
CY2024Q1 pntg General And Professional Liability Insurance Retention Limit Per Claim
GeneralAndProfessionalLiabilityInsuranceRetentionLimitPerClaim
150000 usd
CY2024Q1 pntg Corridor As An Additional Out Of Pocket Retention
CorridorAsAnAdditionalOutOfPocketRetention
500000 usd
CY2024Q1 pntg Workers Compensation Insurance Retention Limit Per Claim
WorkersCompensationInsuranceRetentionLimitPerClaim
250000 usd

Files In Submission

Name View Source Status
0001766400-24-000056-index-headers.html Edgar Link pending
0001766400-24-000056-index.html Edgar Link pending
0001766400-24-000056.txt Edgar Link pending
0001766400-24-000056-xbrl.zip Edgar Link pending
ceocert-exhibit311q12024.htm Edgar Link pending
ceocert-exhibit321q12024.htm Edgar Link pending
cfocert-exhibit312q12024.htm Edgar Link pending
cfocert-exhibit322q12024.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
pntg-20240331.htm Edgar Link pending
pntg-20240331.xsd Edgar Link pending
pntg-20240331_lab.xml Edgar Link unprocessable
pntg-20240331_pre.xml Edgar Link unprocessable
pntg-20240331_htm.xml Edgar Link completed
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
pntg-20240331_def.xml Edgar Link unprocessable
pntg-20240331_cal.xml Edgar Link unprocessable